Immunity and Inflammation in Atherosclerosis

Abstract

There is now overwhelming experimental and clinical evidence that atherosclerosis is a chronic inflammatory disease. Lessons from genome-wide association studies, advanced in vivo imaging techniques, transgenic lineage tracing mice, and clinical interventional studies have shown that both innate and adaptive immune mechanisms can accelerate or curb atherosclerosis. Here, we summarize and discuss the pathogenesis of atherosclerosis with a focus on adaptive immunity. We discuss some limitations of animal models and the need for models that are tailored to better translate to human atherosclerosis and ultimately progress in prevention and treatment.

Keywords

MeSH Terms

Affiliated Institutions

• University of Freiburg DE
• La Jolla Bioengineering Institute US
• Universitäts-Herzzentrum Freiburg-Bad Krozingen DE
• La Jolla Institute for Immunology US
• University of California, San Diego US

Related Publications